No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.
No article has been written about this topic yet.
Be the first one to add some text.
Loading AI-assisted edit mode...
Timeline
Funding rounds
Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
September 2019
People
Name
Role
LinkedIn
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
News
Title
Author
Date
Publisher
Description
MGB Biopharma
January 27, 2021
www.prnewswire.com:443
/PRNewswire/ -- MGB Biopharma, a biopharmaceutical company developing MGB-BP-3, a novel antibacterial, for the treatment of Clostridioides difficile (CDI),...
BioSpace
May 19, 2020
BioSpace
MGB Biopharma, a biopharmaceutical company developing a novel class of anti-infectives, announces that its Phase II clinical study has met its endpoints of safety, efficacy, and dose selection.
Is a
Company attributes
Industry
Location
Crunchbase
Total funding amount (USD)
3,030,000
Latest funding round date
September 2019
